Literature DB >> 21039005

Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma.

Seyed Ali Ahmadi1, Mahnaz Moinfar, Katayoun Gohari Moghaddam, Moslem Bahadori.   

Abstract

BACKGROUND: Tumor growth depends on vascular blood supply. The novel discovery of non-endothelialized vessel-like channels in malignant tumors called vasculogenic mimicry has provided new insights about tumor behavior and also serves as a potential target for drug therapy. Although the association between vasculogenic mimicry and poor prognosis has been established in some tumors, there are only a few studies concerning prostatic carcinoma.
METHODS: Using a histochemical and immunohistochemical dual staining method for PAS-CD34 and special immunohistochemical staining for laminin, we studied the presence and pattern of non-endothelialized channels known as vasculogenic mimicry as well as the quantity of endothelialized vessels designated as microvessel density in usual paraffin sections of 20 low-grade and 20 high-grade prostatic adenocarcinomas by routine light microscopy.
RESULTS: We found a direct positive relationship between higher microvessel density and tumor grade (P<0.001), presence of vascular invasion (P<0.001) and percent of involved tissue (P<0.001); however, no such relationship was found with vasculogenic mimicry and only a weak correlation was noted between vasculogenic mimicry and perineurial invasion (P=0.03).
CONCLUSION: Unlike other cancers and despite the results of in vitro studies on prostatic adenocarcinoma, we were not able to demonstrate a significant relationship between vasculogenic mimicry channels and histologic grading as one of the most important prognostic factors; however, this may be due to an inherent limitation of prostatic tissue imposed by abundant smooth muscle fibers stained by this method. On the other hand, microvessel density scoring appears to be an important, simple, and applicable histologic tool for prostatic cancer evaluation in daily practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039005     DOI: 010136/AIM.009

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  12 in total

1.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.

Authors:  Shiwu Wu; Lan Yu; Zenong Cheng; Wenqing Song; Lei Zhou; Yisheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

3.  Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.

Authors:  Shouru Zhang; Zhongxue Fu; Jinlai Wei; Jinbao Guo; Maoxi Liu; Kunli Du
Journal:  Med Oncol       Date:  2014-12-04       Impact factor: 3.064

4.  Vasculogenic mimicry in bladder cancer and its association with the aberrant expression of ZEB1.

Authors:  Baimou Li; Xiaopeng Mao; Hua Wang; Guanyu Su; Chengqiang Mo; Kaiyuan Cao; Shaopeng Qiu
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

5.  Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.

Authors:  Rui Cheng; Xin-Ran Cai; Kun Ke; Yan-Ling Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

6.  Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro.

Authors:  Dehao Fu; Xianfeng He; Shuhua Yang; Weihua Xu; Tao Lin; Xiaobo Feng
Journal:  BMC Musculoskelet Disord       Date:  2011-06-30       Impact factor: 2.362

7.  In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.

Authors:  Zong-Jun-Lin Liu; Yu-Juan Zhou; Rui-Lin Ding; Fang Xie; Shao-Zhi Fu; Jing-Bo Wu; Ling-Lin Yang; Qing-Lian Wen
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

Review 8.  Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.

Authors:  Hong Ge; Hui Luo
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

9.  Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.

Authors:  Shiwu Wu; Lan Yu; Danna Wang; Lei Zhou; Zenong Cheng; Damin Chai; Li Ma; Yisheng Tao
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

10.  Augmented mast cell infiltration and microvessel density in prostate cancer.

Authors:  Paweł Stawerski; Małgorzata Wagrowska-Danilewicz; Olga Stasikowska-Kanicka; Elżbieta Tuka; Marian Danilewicz
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.